1 / 1

End-Stage Renal Disease Market Insight, Epidemiology and Market Forecast 2030

End-Stage Renal Disease is more common in men than in women. The prevalence of chronic renal failure between the years 2007 and 2011 was higher in women (15.1%) as compared to men (12.1%).<br>About 15% of adults in the US are estimated to have chronic kidney disease. Chronic kidney disease can often be treated before it progresses to end-stage renal failure or leads to other health problems.<br>End-Stage Renal Disease prevalence in the US in 2007 was 1,698 cases per million population. In 2007, Japan also observed relatively high prevalence, i.e., 2,060 cases per million population of End-Stage Renal Disease, which included only people receiving maintenance dialysis.<br>For more details visit: https://www.delveinsight.com/report-store/end-stage-renal-disease-esrd-market<br><br>#ESRD #renaldisease #endstagerenaldisease #ExcretoryDisorders #kidneyDisease #kidneyinjury #renal #RenalFailure

arawat
Download Presentation

End-Stage Renal Disease Market Insight, Epidemiology and Market Forecast 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. End-Stage Renal Disease Market Insight, Epidemiology and Market Forecast 2030 End-Stage Renal Disease Market key facts End-Stage Renal Disease is more common in men than in women. The prevalence of chronic renal failure between the years 2007 and 2011 was higher in women (15.1%) than in men (12.1%). About 15% of adults in the US are estimated to have chronic kidney disease. Chronic kidney disease can often be treated before it progresses to end-stage renal failure or leads to other health problems. End-Stage Renal Disease prevalence in the US in 2007 was 1,698 cases per million population. In 2007, Japan also observed relatively high prevalence, i.e., 2,060 cases per million population of End-Stage Renal Disease, which included only people receiving maintenance dialysis. End-Stage Renal Disease report Key benefits DelveInsight's End-Stage Renal Disease (ESRD) report delivers in-depth understanding of the End-Stage Renal Disease historical and forecasted epidemiology as well as the End-Stage Renal Disease market trends in the 7 major markets i.e. United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The ESRD market report provides End-Stage Renal Disease current treatment practices , market share of the individual therapies, current and forecasted End-Stage Renal Disease (ESRD) market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current End-Stage Renal Disease (ESRD) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. The growth in the End-stage renal disease market is attributed to the various aspects, such as ageing population, diabetic cases, transplantation and dialysis cases. About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

More Related